» Articles » PMID: 30355577

APRT Deficiency: the Need for Early Diagnosis

Overview
Journal BMJ Case Rep
Specialty General Medicine
Date 2018 Oct 26
PMID 30355577
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder which leads to accumulation of poorly soluble 2,8-dihydroxyadenine in kidneys resulting in nephrolithiasis as well as chronic kidney disease from crystal nephropathy. This report describes a 55-year-old previously fit man who presented with shortness of breath and the investigative pathway that eventually led to a diagnosis of APRT deficiency. Early diagnosis has aided in timely institution of allopurinol, thereby improving his renal function and possibility of weaning off renal replacement therapy. Genetic testing has enabled early identification of other family members at risk and prevention of renal failure by commencing xanthine oxidoreductase (XOR) inhibitors. The issues surrounding kidney donation by a member of this family are also discussed. This case represents the importance of awareness and recognition of the signs and symptoms of this rare condition, complications of which can be easily prevented by early institution of XOR inhibitor therapy.

Citing Articles

A case of 2,8-DHA crystalline nephropathy caused by adenine phosphoribosyltransferase deficiency: diagnosis and treatment.

Kunou M, Yamaguchi M, Takahashi H, Kimura Y, Watanabe N, Ito M CEN Case Rep. 2022; 12(3):329-334.

PMID: 36576711 PMC: 10393930. DOI: 10.1007/s13730-022-00768-1.

References
1.
Harambat J, Bollee G, Daudon M, Ceballos-Picot I, Bensman A . Adenine phosphoribosyltransferase deficiency in children. Pediatr Nephrol. 2012; 27(4):571-9. DOI: 10.1007/s00467-011-2037-0. View

2.
Debray H, Cartier P, Temstet A, CENDRON J . Child's urinary lithiasis revealing a complete deficit in adenine phosphoribosyl transferase. Pediatr Res. 1976; 10(8):762-6. DOI: 10.1203/00006450-197608000-00014. View

3.
Halbritter J, Baum M, Hynes A, Rice S, Thwaites D, Gucev Z . Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol. 2014; 26(3):543-51. PMC: 4341487. DOI: 10.1681/ASN.2014040388. View

4.
Edvardsson V, Runolfsdottir H, Thorsteinsdottir U, Agustsdottir I, Oddsdottir G, Eiriksson F . Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with Adenine phosphoribosyltransferase deficiency (APRTd): A clinical trial. Eur J Intern Med. 2017; 48:75-79. PMC: 5817015. DOI: 10.1016/j.ejim.2017.10.007. View

5.
Ceballos-Picot I, Daudon M, Harambat J, Bensman A, Knebelmann B, Bollee G . 2,8-Dihydroxyadenine urolithiasis: a not so rare inborn error of purine metabolism. Nucleosides Nucleotides Nucleic Acids. 2014; 33(4-6):241-52. DOI: 10.1080/15257770.2013.853780. View